Health
Profound Medical Announces Upcoming Investor Events
TORONTO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, is pleased to announce its participation in the following investor events in February. Lake Street Life-Sciences Invitational: Profound is scheduled to participate in a series of one-on-one meetings February 4th-5th in Scottsda
About this update from Profound Medical Corp
[{"type":"image","alt":"Profound Medical Corp.","displaySize":"","headline":null,"caption":"Profound Medical Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":39,"url":"https://media.zenfs.com/en/globenewswire.com/706e95b61981393723638191940b98c5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/oleh9hsLn64FmkZjOMsmoQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTU1O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/706e95b61981393723638191940b98c5","width":300,"height":39}},"lazy":false},{"type":"text","content":"TORONTO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, is pleased to announce its participation in the following investor events in February.","length":359,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Lake Street Life-Sciences Invitational: Profound is scheduled to participate in a series of one-on-one meetings February 4th-5th in Scottsdale, AZ.","length":147,"tagName":"p"}]},{"val":[{"type":"text","content":"BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference: The Company is scheduled to participate in a series of one-on-one meetings February 10th-11th in Snowbird, UT.","length":200,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":347,"olType":false},{"type":"text","content":"Due to the format of the events, no webcasts will be available.","length":63,"tagName":"p"},{"type":"text","content":"About Profound Medical Corp.","length":28,"tagName":"p"},{"type":"text","content":"Profound is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue.","length":164,"tagName":"p"},{"type":"text","content":"Profound is commercializing TULSA-PRO®, a technology that combines real-time MRI, AI-enhanced planning, robotically-driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA Procedure™, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low-, intermediate-, or high-risk prostate cancer; to hybr...